AppLovin : First Quarter 2026 Financial Update

APP

Published on 05/06/2026 at 04:45 pm EDT - Modified on 05/06/2026 at 04:46 pm EDT

Revenue

($ millions)

$406 $504 $576

$678 $711 $835

$999

$1,159 $1,259

$1,405

$1,658

$1,842

Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425 Q126

1Q26: $1.84 billion (+59% Y/Y)

Net Income from Continuing Operations

($ millions)

Net Income from Continuing Operations Margin

33% 38% 42%

52%

60% 62%

$724

$772 $836

61% 59%

$1,102 66%

$1,206

65%

24% 29%

$99 $144 $188

$259 $301

$433 $596

Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425 Q126

1Q26: $1.21 billion (+67% Y/Y), a net margin of 65%

Adjusted EBITDA

($ millions) Adjusted EBITDA Margin

70% 71% 71% 72%

65%

$411 $484 $511

77% 77%

$770

$647

81% 81%

$938

$1,018

$1,158 82%

$1,399

84%

$1,557

85%

$264 $355

Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425 Q126

1Q26: $1.56 billion (+66% Y/Y), an 85% margin

Cash Flow from Operations and Shares Outstanding

($ and shares in millions) Cash Flow from Operations Ending Shares Outstanding

$832 $772

$1,053

$1,314 $1,291

348 336 340

$344

$230 $199

329

334 335

$393

$455

$551

$701

340

338 339

339

338

336

Q223 Q323 Q423 Q124 Q224 Q324 Q424 Q125 Q225 Q325 Q425 Q126

Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. Please see "Non-GAAP Financial Measures" and the reconciliation from GAAP to non-GAAP measures later in this update.

AppLovin Corporation / 1Q26 Financial Update 2

To supplement our financial information presented in accordance with generally accepted accounting principles in the United States ("GAAP"), this financial update includes certain financial measures that are not prepared in accordance with GAAP, including Adjusted EBITDA and Adjusted EBITDA margin. A reconciliation of each such non-GAAP financial measure to the most directly comparable GAAP measure can be found below.

We define Adjusted EBITDA for a particular period as net income, adjusted for loss (income) from discontinued operations, net of income taxes, interest expense, other (income) expense, net (excluding certain recurring items), provision for (benefit from) income taxes, amortization, depreciation and write-offs and as further adjusted for non-operating foreign exchange (gain) loss, stock-based compensation, transaction-related expense, restructuring costs (benefits), as well as certain other items that we believe are not reflective of our core operating performance. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue for the same period.

We believe that the presentation of these non-GAAP financial measures provides useful information to investors regarding our results of operations and operating performance, as they are similar to measures reported by our public competitors and are regularly used by securities analysts, institutional investors, and other interested parties in analyzing operating performance and prospects.

Adjusted EBITDA and Adjusted EBITDA margin are key measures we use to assess our financial performance and are also used for internal planning and forecasting purposes. We believe Adjusted EBITDA and Adjusted EBITDA margin are helpful to investors, analysts, and other interested parties because they can assist in providing a more consistent and comparable overview of our operations across our historical financial periods. We use Adjusted EBITDA and Adjusted EBITDA margin in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance.

These measures have certain limitations in that they do not include the impact of certain expenses that are reflected in our consolidated statement of operations that are necessary to run our business. Our definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may not publish these or similar metrics. Thus, our non-GAAP financial measures should be considered in addition to, not as substitutes for, or in isolation from, measures prepared in accordance with GAAP.

(In thousands, except per share data) (Unaudited)

March 31,

2026

December 31,

2025

Assets

Current assets:

Cash and cash equivalents

$ 2,758,671

$ 2,487,096

Accounts receivable, net

1,958,023

1,819,366

Prepaid expenses and other current assets

130,881

124,330

Total current assets

4,847,575

4,430,792

Property and equipment, net

114,820

122,445

Goodwill

1,523,050

1,539,986

Intangible assets, net

368,996

396,714

Equity method investments

288,669

287,666

Other non-current assets

564,595

482,007

Total assets $ 7,707,705 $ 7,259,610

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$ 697,524

$ 746,977

Accrued and other current liabilities

796,858

586,811

Total current liabilities

1,494,382

1,333,788

Long-term debt

3,514,022

3,512,987

Other non-current liabilities

335,818

278,164

Total liabilities

5,344,222

5,124,939

Stockholders' equity:

Preferred Stock, $0.00003 par value-100,000 shares authorized, no shares

issued and outstanding as of March 31, 2026 and December 31, 2025 - -

Class A, Class B, and Class C Common Stock, $0.00003 par value-1,850,000 (Class A 1,500,000, Class B 200,000, Class C 150,000) shares authorized, 336,294 (Class A 306,087, Class B 30,208, Class C nil) and 338,313 (Class A 307,955, Class B 30,358, Class C nil) shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

11

11

Additional paid-in capital

504,342

446,550

Accumulated other comprehensive loss

(67,767)

(46,987)

Retained earnings

1,926,897

1,735,097

Total stockholders' equity

2,363,483

2,134,671

Total liabilities and stockholders' equity

$ 7,707,705

$ 7,259,610

(In thousands, except per share data) (Unaudited)

Quarter Ended March 31,

2026

2025

Revenue

$ 1,842,449

$ 1,158,974

Costs and expenses:

Cost of revenue

203,632

151,680

Sales and marketing

60,751

59,383

Research and development

94,104

56,406

General and administrative

44,029

51,523

Total costs and expenses

402,516

318,992

Income from operations

1,439,933

839,982

Other income (expense):

Interest expense

(51,159)

(52,888)

Other income, net

42,634

7,512

Total other expense, net

(8,525)

(45,376)

Income before income taxes

1,431,408

794,606

Provision for income taxes

225,795

71,068

Net income from continuing operations

1,205,613

723,538

Loss from discontinued operations, net of income taxes

-

(147,119)

Net income

$ 1,205,613

$ 576,419

Net income (loss) per share attributed to Class A and Class B common stockholders - Basic:

Continuing operations

$ 3.57

$ 2.13

Discontinued operations

-

(0.43)

Basic net income per share

$ 3.57

$ 1.70

Net income (loss) per share attributed to Class A and Class B common stockholders - Diluted:

Continuing operations

$ 3.56

$ 2.10

Discontinued operations

-

(0.43)

Diluted net income per share

$ 3.56

$ 1.67

Weighted-average common shares used to compute net income (loss) per share attributable to Class A and Class B common stockholders:

Basic

337,399

339,837

Diluted

338,729

344,878

(In thousands) (Unaudited)

Quarter Ended March 31,

2026

2025

Operating Activities

Net income

$ 1,205,613

$ 576,419

Adjustments to reconcile net income to net cash provided by operating activities:

Amortization, depreciation and write-offs

33,665

79,887

Goodwill impairment

-

188,943

Stock-based compensation, excluding cash-settled awards

83,372

61,281

Other

(16,478)

8,086

Changes in operating assets and liabilities:

Accounts receivable

(138,098)

(167,382)

Prepaid expenses and other assets

(9,827)

(51,861)

Accounts payable

(49,556)

32,545

Accrued and other liabilities

182,702

103,794

Net cash provided by operating activities

1,291,393

831,712

Investing Activities

Purchase of non-marketable equity securities

-

(18,678)

Other investing activities

(5,247)

(3,986)

Net cash used in investing activities

(5,247)

(22,664)

Financing Activities

Repurchases of common stock

(981,723)

(1,000,911)

Payment of withholding taxes related to net share settlement

(26,874)

(185,667)

Payments of licensed asset obligation

-

(13,532)

Proceeds from issuance of debt

-

200,000

Other financing activities

(3,635)

(2,107)

Net cash used in financing activities

(1,012,232)

(1,002,217)

Effect of foreign exchange rate on cash and cash equivalents

(2,339)

2,782

Net increase (decrease) in cash and cash equivalents, including cash from discontinued operations

271,575

(190,387)

Less: net decrease in cash from discontinued operations

-

(35,873)

Net increase (decrease) in cash and cash equivalents

271,575

(154,514)

Cash and cash equivalents at beginning of the period

2,487,096

697,030

Cash and cash equivalents at end of the period

$ 2,758,671

$ 542,516

(In thousands, except percentages)

The following table provides our Adjusted EBITDA and Adjusted EBITDA Margin and a reconciliation of Net Income to Adjusted EBITDA for the periods presented:

Quarter Ended

2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25 1Q26

Revenue

$406,063 $504,452 $576,489 $678,370 $ 711,015 $835,186 $999,487 $1,158,974 $1,258,754 $1,405,045 $1,657,944 $1,842,449

Net income

80,357 108,639 172,233 236,183 309,969 434,420 599,204 576,419 819,531 835,545 1,102,256 1,205,613

Net margin

20% 22% 30% 35% 44% 52% 60% 50% 65% 59% 66% 65%

Loss (income) from discontinued operations, net of

18,393 35,303 16,229 23,174 (8,987) (1,347) (3,092) 147,119 (47,675) - - -

Net income from continuing

98,750 143,942 188,462 259,357 300,982 433,073 596,112 723,538 771,856 835,545 1,102,256 1,205,613

Net margin from continuing

24 % 29 % 33 % 38 % 42 % 52 % 60 % 62 % 61 % 59 % 66 % 65 %

Adjusted as follows:

Interest expense

50,451 78,051 71,042 73,925 74,418 74,937 93,929 52,888 51,409 51,429 51,290 51,159

Other (income) expense, net

(15,218) 281 19,398 (3,014) (8,763) (3,778) (7,841) (8,644) 12,798 9,079 (28,927) (41,360)

Provision for (benefit from)

14,814 35 19,860 32,253 16,894 34,656 (61,384) 71,068 112,148 185,401 151,098 225,795

Amortization, depreciation

29,489 29,209 31,323 30,917 31,242 32,369 34,263 31,946 31,064 34,978 32,736 33,665

Non-operating foreign

2,263 192 (1,408) 999 412 (2,479) 2,710 (320) (1,210) (570) (1,849) (1,266)

Stock-based compensation

81,938 103,122 81,933 88,944 93,559 77,402 97,526 59,115 34,552 33,767 80,524 83,469

Transaction-related expense1

247 231 52 369 485 26 5 4,583 5,097 6,565 11,334 (49)

Restructuring costs (benefits)1

1,024 - - - 1,936 811 14,512 3,598 633 1,460 217 (107)

Total adjustments

165,008 211,121 222,200 224,393 210,183 213,944 173,720 214,234 246,491 322,109 296,423 351,306

Adjusted EBITDA

$263,758 $355,063 $410,662 $483,750 $ 511,165 $647,017 $769,832 $937,772 $1,018,347 $1,157,654 $1,398,679 $1,556,919

income taxes operations operations

income taxes and write-offs

exchange (gain) loss

Adįusted EBITDA margin 65 % 70 % 71 % 71 % 72 % 77 % 77 % 81 % 81 % 82 % 84 % 85 %

1 Negative amount reflects a reversal of amounts expensed in prior periods

‌APPLO/I N.COM

Disclaimer

Applovin Corporation published this content on May 06, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 06, 2026 at 20:40 UTC.